| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | 264.8 | 236.1 |
| Net income | 19.6 | 8.0 |
| EPS (diluted, $ a share) | $0.14 | $0.06 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +143.8% |
|---|---|
| Revenue, year on year | +12.1% |
| Operating margin | 7.6% |
10-Q filed with the SEC, NASDAQ: INNV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
InnovAge Holding Corp.: key numbers
- Share price
- $9.58Close, Nov 16
- Market cap
- $1.31B
- Shares outstanding
- 136.45MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from InnovAge Holding Corp.
All →InnovAge Holding Financial Results
InnovAge Holding Corp. reported financial results for its fiscal first quarter ended September 30, 2026, with revenue increasing 12.1% year-over-year to $264.8 million. Net income rose significantly to $20.9 million, or $0.14 per share, driven by census growth and disciplined clinical execution. The company ended the quarter with approximately 8,420 participants and $163 million in total cash and short-term investments.
- Term
- Q1 2027
“We are pleased with our strong stat to fiscal 2027, as continued census growth along with disciplined clinical and operational execution drove strong financial performance. Our first quarter results reinforce the progress we have made over the past serval years and our confidence in the long-term potential of the business.”
Patrick Blair, Chief Executive Officer of InnovAge
InnovAge Holding CLO Nicole Damato Sells $32.4K of Stock
Nicole Damato, CLO, sold 3,402 shares of InnovAge Holding Corp. at $9.51 a share, worth $32.4K in total on Oct 22, 2026. Shares held after the trade: 301,495 (-1.1%).
- Value
- $32.4K
- Shares
- 3,402
- Price
- $9.51
- Role
- CLO
- Holding change
- -1.1%
- Trade date
- Oct 22, 2026
InnovAge Holding 10% Owner Welsh Carson Anderson & Stowe XII L.P. Sells $13.9M of Stock
Welsh Carson Anderson & Stowe XII L.P., 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).
- Value
- $13.9M
- Shares
- 1,500,000
- Price
- $9.25
- Role
- 10% Owner
- Holding change
- -1.5%
- Trade date
- Oct 21, 2026
InnovAge Holding 10% Owner Ignite Aggregator LP Sells $13.9M of Stock
Ignite Aggregator LP, 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).
- Value
- $13.9M
- Shares
- 1,500,000
- Price
- $9.25
- Role
- 10% Owner
- Holding change
- -1.5%
- Trade date
- Oct 21, 2026
InnovAge Holding 10% Owner Tco Group Holdings L.P. Sells $13.9M of Stock
Tco Group Holdings L.P., 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).
- Value
- $13.9M
- Shares
- 1,500,000
- Price
- $9.25
- Role
- 10% Owner
- Holding change
- -1.5%
- Trade date
- Oct 21, 2026
InnovAge Holding Signs $92.5M M&A Deal with Barclays Capital Inc.
InnovAge Holding Corp. announced the closing of a secondary offering of 10,000,000 shares of common stock by a selling shareholder at a price of $9.25 per share. The company did not receive any proceeds from the sale, as the shares were previously issued and held by the selling stockholder. The underwriters were also granted a 30-day option to purchase up to an additional 1,500,000 shares.
- Value
- $92.5M
- Counterparty
- Barclays Capital Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC